Where does Merz Pharma GmbH & Co. KGaA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Merz Pharma GmbH & Co. KGaA ranks #5,096 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Merz Pharma GmbH & Co. KGaA hold?

Merz Pharma GmbH & Co. KGaA holds 68 US utility patents granted between 2015 and 2025, spanning 23 technology areas.

What is Merz Pharma GmbH & Co. KGaA's Innovation Score?

Merz Pharma GmbH & Co. KGaA has an Innovation Score of 45.5 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Merz Pharma GmbH & Co. KGaA focus on?

Merz Pharma GmbH & Co. KGaA's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 46 patents, ranking #487 of 7,163 assignees active in that subclass. Grants appear in 23 CPC subclasses total.

Is Merz Pharma GmbH & Co. KGaA's patent grant rate increasing or decreasing?

Merz Pharma GmbH & Co. KGaA's recent grant velocity is +6% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Merz Pharma GmbH & Co. KGaA's patents?

Merz Pharma GmbH & Co. KGaA's patents average 12.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Merz Pharma GmbH & Co. KGaA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Merz Pharma GmbH & Co. KGaA

USPTO PatentsView assignee record - 68 granted patents across 23 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Merz ranks #5,096 of 49,997 tracked US assignees by granted-patent volume, with 68 patents across 23 technology areas.

#5,096
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 12.8
avg claims per patent: +6%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5096 · Foreign Corporation #5,096 · 68 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 68 grants
UPPER-Q #5,096/49,997
PHOTO-FINISH Lvmh Recherche
CPC-FOCUS A61K · 23 areas
INNOV-PAR 45.5/100
CLAIMS-RICH 12.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +6% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Lvmh Recherche (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Alpha Omega… · near

46
Mallinckrodt · near

46
Merz Pharma & KGaA · this assignee

46
Affymetrix · near

46
Jxtg Nippon OIL &… · near

46
3D Lighting… · lowest

7

What this shows Merz's Innovation Score is 45.5/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Merz's grants concentrate

Merz Pharma GmbH & Co. KGaA is a focused PatentsView assignee: 23 CPC subclasses with 67.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (11 grants) versus a trough of 2 in 2023. By volume, Merz sits between Lvmh Recherche and Ningbo University.

Merz's three-year grant acceleration

Merz Pharma GmbH & Co. KGaA shows 18 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Lvmh Recherche

68
Maquet Cardiovasc…

68
Medizinische Hoch…

68
Medtronic Holding…

68
Middle Chart

68
Nelson Irrigation

68
Nutrition & Biosc…

68
Ningbo University

68
Merz Pharma & Kgaa ◀

68

What this shows Merz holds 68 patents at rank #5,094, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Merz

By rank, the assignees closest to #5,094 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Merz's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Merz, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Merz ranks #487 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Mallinckrodt LLC 46 Alpha Omega Engineering Ltd. 46 Affymetrix, Inc. 46 Jxtg Nippon OIL & Energy Corporation 46

Similar claim depth

Nearest assignees by average claims per patent (12.8 here).

Moxa Inc. 12.8 avg Universita Degli Studi DI Palermo 12.8 avg JGC Catalysts and Chemicals Ltd. 12.8 avg Cognis IP Management GmbH 12.8 avg

Merz's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Merz Pharma GmbH & Co. KGaA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	16.2%
2016	7	10.3%
2017	4	5.9%
2018	5	7.4%
2019	4	5.9%
2020	8	11.8%
2021	7	10.3%
2022	9	13.2%
2023	2	2.9%
2024	7	10.3%
2025partial year	4	5.9%

Which technologies does Merz Pharma GmbH & Co. KGaA patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 46

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 33

Y02A - Technologies FOR Adaptation TO Climate Change 32

C12Y - Enzymes 24

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 24

C07K - Peptides 21

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 17

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 12

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 9

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

C08B - POLYSACCHARIDES; Derivatives Thereof 7

C08L - Compositions OF Macromolecular Compounds 6

Y10T - Technical Subjects Covered BY Former US Classification 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 2

Top 15 of 23 technology areas

Where it ranks

Overall rank by patents

#5,096

of 49,997 tracked assignees

Innovation Score

45.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Merz Pharma GmbH & Co. KGaA's patent record in context - here's where to go next.

Merz Pharma GmbH & Co. KGaA's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 67.6% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #5,096 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Merz Pharma GmbH & Co. KGaA against Lvmh Recherche, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.